Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Why this is new/important: Clinical trials have previously shown that SGLT-2 inhibitor drugs can cause weight loss in some patients, but currently these drugs are only approved to lower blood glucose levels
Rising patient awareness regarding obesity treatment and personalized healthcare solutions is further supporting adoption across the region
I just like the idea of customiz
This rise is fuelling a parallel increase in obesity-related diseases, including type 2 diabetes [3], cardiovascular disease [4], and, critically, cancer
doi: 10.7717/peerj.5355 251 RimoldiS.TerovaG.AscioneC.GiannicoR.BrambillaF
US$ 25.64
US$ 23.53
US$ 24.54
US$ 25.55
US$ 26.98
